Bangkok Dusit Medical Services Public
(OTC) BDUUF
Bangkok Dusit Medical Services Public Financials at a Glance
Market Cap
$10.34B
Revenue (TTM)
$111.48B
Net Income (TTM)
$15.85B
EPS (TTM)
$0.03
P/E Ratio
21.48
Dividend
$0.02
Beta (Volatility)
0.00 (Low)
Dividend
$0.02
Beta (Volatility)
0.00 (Low)
Price
$0.65
Volume
875
Open
$0.65
Price
$0.65
Volume
875
Open
$0.65
Previous Close
$0.65
Daily Range
$0.65 - $0.65
52-Week Range
$0.58 - $0.65
Dividend
$0.02
Beta (Volatility)
0.00 (Low)
Price
$0.65
Volume
875
Open
$0.65
Previous Close
$0.65
Daily Range
$0.65 - $0.65
52-Week Range
$0.58 - $0.65
BDUUF News
BDUUF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bangkok Dusit Medical Services Public
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
36,252
CEO
Kongkiat Kespechara
Website
www.bangkokhospital.comHeadquarters
Bangkok, 10310, TH
BDUUF Financials
Key Financial Metrics (TTM)
Gross Margin
36%
Operating Margin
17%
Net Income Margin
14%
Return on Equity
15%
Return on Capital
14%
Return on Assets
10%
Earnings Yield
4.66%
Dividend Yield
0.04%
Payout Ratio
75.19%
Stock Overview
Market Cap
$10.34B
Shares Outstanding
15.89B
Volume
875
Short Interest
0.00%
Avg. Volume
30.738
Financials (TTM)
Gross Profit
$38.89B
Operating Income
$18.45B
EBITDA
$25.29B
Operating Cash Flow
$23.43B
Capital Expenditure
$10.41B
Free Cash Flow
$13.02B
Cash & ST Invst.
$7.24B
Total Debt
$17.49B
Bangkok Dusit Medical Services Public Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$28.43B
+3.7%
Gross Profit
$10.00B
-3.6%
Gross Margin
35.16%
N/A
Market Cap
$10.34B
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$3.69B
-14.8%
EBITDA
$5.87B
-16.0%
Quarterly Fundamentals
Net Cash
$17.84B
-85.0%
Accounts Receivable
$11.98B
+0.2%
Inventory
$3.42B
+31.3%
Long Term Debt
$18.20B
+34.4%
Short Term Debt
$6.87B
+42.7%
Return on Assets
10.03%
N/A
Return on Invested Capital
14.35%
N/A
Free Cash Flow
$2.01B
+258.2%
Operating Cash Flow
$4.25B
-1.5%